2024 r.

Maurer Marcus, Ensina Luis Felipe, Giménez-Arnau Ana Maria, Sussman Gordon, Hide Michihiro, Saini Sarbjit, Grattan Clive, Fomina Daria, Rigopoulos Dimitrios, Berard Frederic, Canonica Giorgio Walter, Rockmann Heike, Irani Carla, Szepietowski Jacek C., Leflein Jeffrey, Bernstein Jonathan A., Peter Jonny G., Kulthanan Kanokvalai, Godse Kiran, Ardusso Ledit, Ukhanova Olga, Staubach Petra, Sinclair Rodney, Gogate Shaila, Thomsen Simon Francis, Tanus Tonny, Ye Young Min, Burciu Alis, Barve Avantika, Modi Darshna, Scosyrev Emil, Hua Eva, Letzelter Kerstin, Varanasi Vineeth, Pateka Manmath, Severin Thomas, Reich Adam Andrzej; "Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria : results of two phase 3 randomised controlled trials", Lancet, 2024 : Vol. 403, nr 10422, p. 147-159, 200 pkt.

Jain Vipul, Giménez-Arnau Ana, Hayama Koremasa, Reich Adam Andrzej, Carr Warner, Tillinghast Jeffrey, Dahale Swapnil, Lheritier Karine, Walsh Pauline, Zharkov Artem, Hugot Sophie, Haemmerle Sibylle; "Remibrutinib demonstrates favorable safety profile and sustained efficacy in chronic spontaneous urticaria over 52 weeks", Journal of Allergy and Clinical Immunology, 2024 : Vol. 153, iss. 2, p. 479-486.e4, 200 pkt.

Baran Joanna, Baran Rafał, Bartosiewicz Anna, Czenczek-Lewandowska Ewelina, Dereń Katarzyna, Leszczak Justyna, Łuszczki Edyta, Sobek Grzegorz, Weres Aneta, Matłosz Piotr, Mazur Artur, Wyszyńska Justyna; "Worldwide trends in underweight and obesity from 1990 to 2022 : a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults", Lancet, 2024 : Vol. 403, nr 10431, p. 1027-1050, 200 pkt.